Gel
Stent Market, End User (Eye Research Institutes, Eye Clinics, and
Hospitals), and By Geography (North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity
Analysis, 2018 – 2026
Stent is a small expandable tube
used for the treatment of narrowed arteries. It is used to prevent bursting of
arteries and improve blood flow of weak arteries. Soft gelatin is used for the
preparation of gel stent. When gel stent is injected, it gets hydrated and
drains the aqueous humor in the sub-conjunctival space, which lowers the
intraocular pressure. This procedure is minimally invasive.
Gel Stent Market – Dynamics
Rising population above the age
of 40 is a major factor driving growth of the market. For instance in 2017, 2.7
million out of 3 million Americans are suffering with glaucoma were aged 40 and
older. This is attributed to high chances of people aged 40 and above suffering
from miosis, in which excessive contraction of eye increase in the elder
population. Glaucoma is one of the leading cause for blindness. Increasing
demand for minimally invasive procedures and increasing incidences of glaucoma
are other factors that are expected to drive growth of the global gel stent
market over the forecast period. According to Glaucoma Research Society in U.S.
in 2017, more than 120,000 are blind from glaucoma.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2404
However, high cost of the gel
stent, lack of availability of healthcare professionals and lack of awareness
regarding the technique are factors that hinder growth of the gel stent market.
Gel Stent Market – Regional
Insights
On the basis of geography, the
global gel stent market is segmented into North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa. North America is expected to hold
dominant position in the gel stent market, followed by Europe during the
forecast period. The U.S. holds dominant position in the market in this region
due to continuous technological advancements and developed healthcare
infrastructure.
According to American Glaucoma
Society, glaucoma is the second leading cause of blindness in the U.S. and
globally. In the U.S, over 3 million people suffer from glaucoma while only 50%
are aware of the diagnosis. In 2016, over 120,000 people in the U.S. suffered
from blindness due to glaucoma.
According to the World Health
Organization (WHO), Asians have more chances of suffering from close angle
glaucoma while people from Europe or Africa are more likely to suffer from
primary open angle glaucoma. According to WHO, In South India, glaucoma
prevalence is 2.6%. In Africa, the prevalence of glaucoma is 1–2%, but can rise
to about 10% in the Caribbean.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/gel-stent-market-2404
Gel Stent Market - Competitive
Landscape
Key players are focusing on
research and development, in order to develop technologically advanced products
and enhance their product portfolio. The XEN (Allergan) received approval from
the U.S. Food and Drug Administration (FDA) in November 2016 and launched in
the U.S. in early 2017. Major players operating in the global gel stent market
include Allergan, Alcon, Innfocus and Glaukos Corp.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2404
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment